165 related articles for article (PubMed ID: 30219449)
21. Mistletoe in conventional oncological practice: exemplary cases.
Legnani W
Integr Cancer Ther; 2008 Sep; 7(3):162-71. PubMed ID: 18956494
[TBL] [Abstract][Full Text] [Related]
22. Case reports of sarcoma patients with optimized lectin-oriented mistletoe extract therapy.
Kirsch A; Hajto T
J Altern Complement Med; 2011 Oct; 17(10):973-9. PubMed ID: 22010781
[TBL] [Abstract][Full Text] [Related]
23. Paediatric medulloblastoma cells are susceptible to Viscum album (Mistletoe) preparations.
Zuzak TJ; Rist L; Eggenschwiler J; Grotzer MA; Viviani A
Anticancer Res; 2006; 26(5A):3485-92. PubMed ID: 17094471
[TBL] [Abstract][Full Text] [Related]
24. Safety of higher dosages of Viscum album L. in animals and humans--systematic review of immune changes and safety parameters.
Kienle GS; Grugel R; Kiene H
BMC Complement Altern Med; 2011 Aug; 11():72. PubMed ID: 21871125
[TBL] [Abstract][Full Text] [Related]
25. Viscum album L. Therapy in Oncology: An Update on Current Evidence.
Thronicke A; Schad F; Debus M; Grabowski J; Soldner G
Complement Med Res; 2022; 29(4):362-368. PubMed ID: 35325897
[TBL] [Abstract][Full Text] [Related]
26. Patients are talking about ... Iscador (mistletoe).
Decker G
Clin J Oncol Nurs; 2001; 5(4):183-4. PubMed ID: 12690624
[TBL] [Abstract][Full Text] [Related]
27. ViscumTT induces apoptosis and alters IAP expression in osteosarcoma in vitro and has synergistic action when combined with different chemotherapeutic drugs.
Kleinsimon S; Kauczor G; Jaeger S; Eggert A; Seifert G; Delebinski C
BMC Complement Altern Med; 2017 Jan; 17(1):26. PubMed ID: 28061770
[TBL] [Abstract][Full Text] [Related]
28. [Viscum album L. (Iscador) in the cat: tolerance, adverse reactions and indications].
Glardon ; Pache ; Magnenat ; Pin ; Parvis
Schweiz Arch Tierheilkd; 2014 Aug; 156(8):381-8. PubMed ID: 25082635
[TBL] [Abstract][Full Text] [Related]
29. [Mistletoe in the treatment of cancer].
Bruseth S; Enge A
Tidsskr Nor Laegeforen; 1993 Mar; 113(9):1058-60. PubMed ID: 8493669
[TBL] [Abstract][Full Text] [Related]
30. Preclinical Evaluation of Antitumoral and Cytotoxic Properties of Viscum album Fraxini Extract on Pediatric Tumor Cells.
Menke K; Schwermer M; Schramm A; Zuzak TJ
Planta Med; 2019 Oct; 85(14-15):1150-1159. PubMed ID: 31590196
[TBL] [Abstract][Full Text] [Related]
31. Immunomodulatory effects of Viscum album extracts on natural killer cells: review of clinical trials.
Braedel-Ruoff S
Forsch Komplementmed; 2010 Apr; 17(2):63-73. PubMed ID: 20484913
[TBL] [Abstract][Full Text] [Related]
32. Tolerability of an extract of European mistletoe among immunocompromised and healthy individuals.
Gorter RW; van Wely M; Reif M; Stoss M
Altern Ther Health Med; 1999 Nov; 5(6):37-44, 47-8. PubMed ID: 10550904
[TBL] [Abstract][Full Text] [Related]
33. Retrolective, comparative, epidemiological cohort study with parallel groups design for evaluation of efficacy and safety of drugs with "well-established use".
Bock PR; Friedel WE; Hanisch J; Karasmann M; Schneider B
Forsch Komplementarmed Klass Naturheilkd; 2004 Aug; 11 Suppl 1():23-9. PubMed ID: 15353899
[TBL] [Abstract][Full Text] [Related]
34. Neurophysiological effects of mistletoe (Viscum album L.) on isolated rat intestines.
Radenkovic M; Ivetic V; Popovic M; Mimica-Dukic N; Veljkovic S
Phytother Res; 2006 May; 20(5):374-7. PubMed ID: 16619366
[TBL] [Abstract][Full Text] [Related]
35. Health services research of integrative oncology in palliative care of patients with advanced pancreatic cancer.
Axtner J; Steele M; Kröz M; Spahn G; Matthes H; Schad F
BMC Cancer; 2016 Aug; 16():579. PubMed ID: 27485618
[TBL] [Abstract][Full Text] [Related]
36. Patient' and social aspects related to complementary mistletoe therapy in patients with breast cancer: A systematic review commissioned by the German agency for Health Technology Assessment.
Steigenberger C; Schnell-Inderst P; Flatscher-Thöni M; Plank LM; Siebert U
Eur J Oncol Nurs; 2023 Aug; 65():102338. PubMed ID: 37321128
[TBL] [Abstract][Full Text] [Related]
37. Fever Therapy With Intravenously Applied Mistletoe Extracts for Cancer Patients: A Retrospective Study.
Schläppi M; Ewald C; Kuehn JJ; Weinert T; Huber R
Integr Cancer Ther; 2017 Dec; 16(4):479-484. PubMed ID: 27387685
[TBL] [Abstract][Full Text] [Related]
38. Immunological response to mistletoe (Viscum album L.) in cancer patients: a four-case series.
Gardin NE
Phytother Res; 2009 Mar; 23(3):407-11. PubMed ID: 19003944
[TBL] [Abstract][Full Text] [Related]
39. Phase II study of viscum fraxini-2 in patients with advanced hepatocellular carcinoma.
Mabed M; El-Helw L; Shamaa S
Br J Cancer; 2004 Jan; 90(1):65-9. PubMed ID: 14710208
[TBL] [Abstract][Full Text] [Related]
40. Adjuvant intravesical treatment of superficial bladder cancer with a standardized mistletoe extract.
Elsässer-Beile U; Leiber C; Wolf P; Lucht M; Mengs U; Wetterauer U
J Urol; 2005 Jul; 174(1):76-9. PubMed ID: 15947582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]